127 related articles for article (PubMed ID: 37201765)
21. Developing Biologics Tablets: The Effects of Compression on the Structure and Stability of Bovine Serum Albumin and Lysozyme.
Wei Y; Wang C; Jiang B; Sun CC; Middaugh CR
Mol Pharm; 2019 Mar; 16(3):1119-1131. PubMed ID: 30698973
[TBL] [Abstract][Full Text] [Related]
22. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K
Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134
[TBL] [Abstract][Full Text] [Related]
23. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
24. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
Chattoraj S; Sun CC
J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the effect of glidants on tablet sticking propensity of ketoprofen using powder rheology.
Parekh BV; Saddik JS; Patel DB; Dave RH
Int J Pharm; 2023 Mar; 635():122710. PubMed ID: 36773731
[TBL] [Abstract][Full Text] [Related]
26. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
27. How suitable is the measurement of take-off forces for detection of sticking during direct compression of various ibuprofen tablet formulations?
Saniocki I; Sakmann A; Leopold CS
Pharm Dev Technol; 2013 Feb; 18(1):257-65. PubMed ID: 22931059
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
Remenar JF; Peterson ML; Stephens PW; Zhang Z; Zimenkov Y; Hickey MB
Mol Pharm; 2007; 4(3):386-400. PubMed ID: 17497886
[TBL] [Abstract][Full Text] [Related]
29. Development of a New Punch Head Shape to Replicate Scale-Up Issues on a Laboratory Tablet Press III: Replicating Sticking Phenomenon Using the SAS Punch and Evaluation by Checking the Tablet Surface Using 3-D Laser Scanning Microscope.
Ito M; Aoki S; Uchiyama J; Yamato K
J Pharm Sci; 2018 Aug; 107(8):2144-2151. PubMed ID: 29684408
[TBL] [Abstract][Full Text] [Related]
30. Toward a Molecular Understanding of the Impact of Crystal Size and Shape on Punch Sticking.
Paul S; Taylor LJ; Murphy B; Krzyzaniak JF; Dawson N; Mullarney MP; Meenan P; Sun CC
Mol Pharm; 2020 Apr; 17(4):1148-1158. PubMed ID: 32058728
[TBL] [Abstract][Full Text] [Related]
31. Single-step Coprocessing of Cohesive Powder via Mechanical Dry Coating for Direct Tablet Compression.
Qu L; Stewart PJ; Hapgood KP; Lakio S; Morton DAV; Zhou QT
J Pharm Sci; 2017 Jan; 106(1):159-167. PubMed ID: 27665128
[TBL] [Abstract][Full Text] [Related]
32. Understanding the role of magnesium stearate in lowering punch sticking propensity of drugs during compression.
Gunawardana CA; Kong A; Wanapun D; Blackwood DO; Travis Powell C; Krzyzaniak JF; Thomas MC; Kresevic JE; Sun CC
Int J Pharm; 2023 Jun; 640():123016. PubMed ID: 37156307
[TBL] [Abstract][Full Text] [Related]
33. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
34. Predicting lubricants effect on tablet sticking using ketoprofen as model drug and evaluating sticking propensity using different metals and powder rheology.
Patel DB; Dave RH
Int J Pharm; 2021 Sep; 606():120913. PubMed ID: 34298104
[TBL] [Abstract][Full Text] [Related]
35. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
36. Direct compression tablet formulation of celecoxib enabled with a pharmaceutical solvate.
Wang K; Sun CC
Int J Pharm; 2021 Mar; 596():120239. PubMed ID: 33484921
[TBL] [Abstract][Full Text] [Related]
37. Mechanism and Kinetics of Punch Sticking of Pharmaceuticals.
Paul S; Taylor LJ; Murphy B; Krzyzaniak J; Dawson N; Mullarney MP; Meenan P; Sun CC
J Pharm Sci; 2017 Jan; 106(1):151-158. PubMed ID: 27649886
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Celecoxib-Eutectic Mixture Particles via Supercritical CO
Hong SH; Dinh L; Abuzar SM; Lee ES; Hwang SJ
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893805
[TBL] [Abstract][Full Text] [Related]
39. Nucleation During Storage Impeded Supersaturation in the Dissolution Process of Amorphous Celecoxib.
Song J; Kawakami K
Mol Pharm; 2023 Aug; 20(8):4050-4057. PubMed ID: 37413788
[TBL] [Abstract][Full Text] [Related]
40. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
